Abstract
Men living with multiple long-term conditions and obesity are under-represented in behavioural weight management trials. Within an effective text messaging and financial incentives trial, our aim was to explore retention, secondary mental health and wellbeing outcomes, and experiences of men with multiple long-term conditions.
Methods Mixed methods process evaluation within a 3-group randomised controlled trial: behavioural text messages with financial incentives, texts alone and waiting-list control, for 583 of 585 men with obesity. Trial retention, mental health and wellbeing outcomes, and experiences were compared for 235 (40%) participants with multiple long-term conditions, 181 (31%) with single conditions, 167 (29%) with no conditions, and for 165 (29%) with disability. Semi-structured interviews, analysed using the Framework method, explored experiences with weight trajectories. Concurrent descriptive and qualitative analyses were undertaken.
Results Of the 235 (40%) trial participants with multiple long-term conditions, 99 were disabled and 93 were living in deprived areas. Participants with multiple long-term conditions and/or disability were older, fewer had a degree level qualification, and fewer were in full time work. Retention at 12 months was higher for men with disability (76%) or no long-term conditions (75%), and lower for men with diabetes (65%). Self-reported weight stigma, wellbeing and quality of life scores improved or stayed the same for men living with multiple long-term conditions in the intervention groups, however, results for anxiety and depression screening scores were inconsistent. Participant experiences indicated complex dynamic health, social and life situations which could provide motivation to lose weight for some but not others. Hospitalisation and poor mobility, with inability to exercise, was de-motivating for making changes to reach weight loss targets.
Conclusion Men with multiple long-term conditions varied from very successful weight loss and improved health, to not prioritising or feeling helped by the programme or disengagement due to immobility or diabetes.
Competing Interest Statement
Dr Hoddinott reported receiving grants from National Institute for Health Research (NIHR), and the Chief Scientist Office (CSO), Scotland, during the conduct of the study and serving as chair or member of Independent Trial Steering Committees unrelated to weight management trials; being a member of the NIHR School for Primary Care Research Funding panel. Dr Dombrowski reported receiving grants from the NIHR during the conduct of the study. Mr Swingler reported receiving grants from NIHR during the conduct of the study. Dr Cotton reported receiving grants from NIHR HTA (grant funding to institution) during the conduct of the study. Dr Avenell reported receiving grants from National Institute for Health and Care Research funding project in submission during the conduct of the study. Dr Hunt reported receiving grants from NIHR, CSO, the Australian Heart Foundation, and the Department of Health, Australia, during the conduct of the study; and serving as chair of the Health Improvement, Protection and Services Committee of the Chief Scientist Office. Dr MacLean reported receiving grants from the NIHR during the conduct of the study. Dr McKinley reported receiving grants from NIHR during the conduct of the study. Ms Torrens reported receiving grants from NIHR during the conduct of the study. Dr Turner reported receiving grants from NIHR during the conduct of the study and having had served as a member of the NIHR Health Technology Assessment (HTA) commissioning board, December 2017 to September 2020. Mr MacLennan reported receiving grants from the NIHR during the conduct of the study. No other disclosures were reported.
Clinical Trial
ISRCTN91974895
Clinical Protocols
https://www.fundingawards.nihr.ac.uk/award/NIHR129703
Funding Statement
This trial was funded by the National Institute for Health and Care Research (NIHR), UK (Ref: NIHR 129703) using UK aid from the UK Government to support global health research. The research team were invited to apply for additional funding from NIHR in 2021 to investigate UK policy priority areas: mental health conditions and multiple long-term conditions within the Game of Stones trial. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the UK government. This project was supported by NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board; NHS Greater Glasgow and Clyde; NRS Primary Care Network and HSC R&D Division of the Public Health Agency [HSC R&D Award Reference PHR Project: NIHR129703]. The Funder did not have a role in the design (beyond their review of the application), and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The Nursing, Midwifery and Allied Health Professions Research Unit, the Health Services Research Unit (HSRU) and the Health Economics Research Unit (HERU) were core funded by the Chief Scientist.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was granted by North of Scotland Research Ethics Committee 2 (reference 20/NS/014).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data collected for the study, including individual patient data and a data dictionary defining each field in the data set will be made available to others. The participant data will be de-identified and will comply with the ethical and regulatory approvals for the study. Requests for access to data can be sent by email to chart{at}abdn.ac.uk and will be considered by the study team.
